Literature DB >> 15370726

Severe interstitial pneumonitis associated with infliximab therapy.

S Chatterjee.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15370726     DOI: 10.1080/03009740410005836

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


× No keyword cloud information.
  9 in total

1.  A fatal case of acute exacerbation of interstitial lung disease in a patient with rheumatoid arthritis during treatment with tocilizumab.

Authors:  Shin-Ya Kawashiri; Atsushi Kawakami; Noriho Sakamoto; Yuji Ishimatsu; Katsumi Eguchi
Journal:  Rheumatol Int       Date:  2010-05-18       Impact factor: 2.631

Review 2.  Unresolved issues in biologic therapy for rheumatoid arthritis.

Authors:  Ronald F van Vollenhoven
Journal:  Nat Rev Rheumatol       Date:  2011-03-08       Impact factor: 20.543

3.  Tumor necrosis factor-α accelerates the resolution of established pulmonary fibrosis in mice by targeting profibrotic lung macrophages.

Authors:  Elizabeth F Redente; Rebecca C Keith; William Janssen; Peter M Henson; Luis A Ortiz; Gregory P Downey; Donna L Bratton; David W H Riches
Journal:  Am J Respir Cell Mol Biol       Date:  2014-04       Impact factor: 6.914

Review 4.  Pulmonary complications of tumor necrosis factor-targeted therapy.

Authors:  Krishna Thavarajah; Peggy Wu; Elisa J Rhew; Anjana K Yeldandi; David W Kamp
Journal:  Respir Med       Date:  2009-02-07       Impact factor: 3.415

5.  Protective Effect of Infliximab, a Tumor Necrosis Factor-Alfa Inhibitor, on Bleomycin-Induced Lung Fibrosis in Rats.

Authors:  Nejat Altintas; Mustafa Erboga; Cevat Aktas; Bulent Bilir; Murat Aydin; Aysun Sengul; Zehra Ates; Birol Topcu; Ahmet Gurel
Journal:  Inflammation       Date:  2016-02       Impact factor: 4.092

6.  Interstitial pneumonitis associated with infliximab therapy without methotrexate treatment.

Authors:  Hirofumi Taki; Yukio Kawagishi; Koichiro Shinoda; Hiroyuki Hounoki; Reina Ogawa; Eiji Sugiyama; Kazuyuki Tobe
Journal:  Rheumatol Int       Date:  2009-12       Impact factor: 2.631

Review 7.  Rheumatoid arthritis-associated interstitial lung disease.

Authors:  Joshua J Solomon; Kevin K Brown
Journal:  Open Access Rheumatol       Date:  2012-03-05

Review 8.  Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases.

Authors:  Sherine E Gabriel; Kaleb Michaud
Journal:  Arthritis Res Ther       Date:  2009-05-19       Impact factor: 5.156

Review 9.  Management of Rheumatoid Arthritis Patients with Interstitial Lung Disease: Safety of Biological Antirheumatic Drugs and Assessment of Pulmonary Fibrosis.

Authors:  Shunsuke Mori
Journal:  Clin Med Insights Circ Respir Pulm Med       Date:  2015-09-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.